Case Study 4 – Successful US/EU Marketing Applications for Big Pharma
Syner-G
AUGUST 9, 2022
As a result of repeat business, IMPACT (now part of Syner-G BioPharma Group) was contracted by a large, global pharmaceutical company to author the CSRs and accompanying submission documents to support a simultaneous US and EU submission for a combination respiratory product. and 2.7.2), and the Clinical Overview (Module 2.5).
Let's personalize your content